M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens

Infection and Immunity

Volumn 77, Issue 7, 2009, Pages 2962-2970

  Chionh, Yok Teng ^a   Wee, Janet L K ^a   Every, Alison L ^a   Ng, Garrett Z ^a   Sutton, Philip ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GLYCAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LECTIN; ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; FEMALE; HELICOBACTER PYLORI; IMMUNE RESPONSE; MOUSE; MUCOSA CELL; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CAMPYLOBACTER INFECTIONS; COLONY COUNT, MICROBIAL; FEMALE; HELICOBACTER INFECTIONS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; PLANT LECTINS; SEVERITY OF ILLNESS INDEX; STOMACH; VACCINES, INACTIVATED;

EID: 67650074251     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01522-08     Document Type: Article

References (38)

1. Anosova, N., S. Chabot, V. Shreedhar, J. Borawski, B. Dickinson, and M. Neutra. 2008. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 1:59-67.
2. Autenrieth, I. B., V. Schuster, J. Ewald, D. Harmsen, and H. W. Kreth. 1996. An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin. Clin. Infect. Dis. 23:526-531.
3. Baqar, S., L. A. Applebee, and A. L. Bourgeois. 1995. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect. Immun. 63:3731-3735.
4. Blanchard, T. G., S. J. Czinn, R. W. Redline, N. Sigmund, G. Harriman, and J. G. Nedrud. 1999. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell. Immunol. 191:74-80.
5. Chen, H., V. Torchilin, and R. Langer. 1996. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13:1378-1383.
6. Clark, M. A., M. A. Jepson, and B. H. Hirst. 1995. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum. Histochem. Cell Biol. 104:161-168.
7. Clark, M. A., M. A. Jepson, N. L. Simmons, and B. H. Hirst. 1995. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res. 282:455-461.
8. Corr, S. C., C. C. Gahan, and C. Hill. 2008. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol. Med. Microbiol. 52:2-12.
9. Correa, P., and J. Houghton. 2007. Carcinogenesis of Helicobacter pylori. Gastroenterology 133:659-672.
10. Couch, R. B. 2004. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N. Engl. J. Med. 350:860-861.
11. Dunkley, M. L., S. J. Harris, R. J. McCoy, M. J. Musicka, F. M. Eyers, L. G. Beagley, P. J. Lumley, K. W. Beagley, and R. L. Clancy. 1999. Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein. FEMS Immunol. Med. Microbiol. 24:221-225.
12. Ermak, T. H., R. Ding, B. Ekstein, J. Hill, G. A. Myers, C. K. Lee, J. Pappo, H. K. Kleanthous, and T. P. Monath. 1997. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology 113:1118-1128.
13. Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, H. Kleanthous, and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:2277-2288.
14. Foster, N., M. A. Clark, M. A. Jepson, and B. H. Hirst. 1998. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16:536-541.
15. Gebert, A., H. J. Rothkotter, and R. Pabst. 1996. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:91-159.
16. Giannasca, P. J., K. T. Giannasca, A. M. Leichtner, and M. R. Neutra. 1999. Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun. 67:946-953.
17. Graham, J. R. 1996. Helicobacter pylori, gastric ulcer, and duodenal ulcer. N. Engl. J. Med. 335:1842.
18. Gupta, P. N., K. Khatri, A. K. Goyal, N. Mishra, and S. P. Vyas. 2007. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J. Drug Target. 15:701-713.
19. Hynes, S. O., S. Hirmo, T. Wadstrom, and A. P. Moran. 1999. Differentiation of Helicobacter pylori isolates based on lectin binding of cell extracts in an agglutination assay. J. Clin. Microbiol. 37:1994-1998.
20. Jang, M. H., M. N. Kweon, K. Iwatani, M. Yamamoto, K. Terahara, C. Sasakawa, T. Suzuki, T. Nochi, Y. Yokota, P. D. Rennert, T. Hiroi, H. Tamagawa, H. Iijima, J. Kunisawa, Y. Yuki, and H. Kiyono. 2004. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 101:6110-6115.
21. Jepson, M. A., M. A. Clark, and B. H. Hirst. 2004. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Adv. Drug Deliv. Rev. 56:511-525.
22. Lavelle, E. C., G. Grant, U. Pfuller, and D. T. O'Hagan. 2004. Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J. Drug Target. 12:89-95.
23. Manocha, M., P. C. Pal, K. T. Chitralekha, B. E. Thomas, V. Tripathi, S. D. Gupta, R. Paranjape, S. Kulkarni, and D. N. Rao. 2005. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine 23:5599-5617.
24. Michetti, P., C. Kreiss, K. L. Kotloff, N. Porta, J. L. Blanco, D. Bachmann, M. Herranz, P. F. Saldinger, I. Corthesy-Theulaz, G. Losonsky, R. Nichols, J. Simon, M. Stolte, S. Ackerman, T. P. Monath, and A. L. Blum. 1999. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116:804-812.
25. Moore, J., M. Curran, D. Wareing, A. Fox, N. Boyd, G. Glynn, B. Millar, G. Daly, and P. Murphy. 2001. Investigation of infection with Campylobacter jejuni in a man with hypogammaglobulinaemia using PCR-single-stranded conformational polymorphism (PCR-SSCP) typing. Int. J. Med. Microbiol. 291:21-25.
26. Moran, A. P., E. Sturegard, H. Sjunnesson, T. Wadstrom, and S. O. Hynes. 2000. The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model. FEMS Immunol. Med. Microbiol. 29:263-270.
27. Nochi, T., Y. Yuki, A. Matsumura, M. Mejima, K. Terahara, D. Y. Kim, S. Fukuyama, K. Iwatsuki-Horimoto, Y. Kawaoka, T. Kohda, S. Kozaki, O. Igarashi, and H. Kiyono. 2007. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 204:2789-2796.
28. Pappo, J., D. Torrey, L. Castriotta, A. Savinainen, Z. Kabok, and A. Ibraghimov. 1999. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67:337-341.
29. Raghavan, S., M. Hjulstrom, J. Holmgren, and A. M. Svennerholm. 2002. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect. Immun. 70:6383-6388.
30. Sharma, R., E. J. van Damme, W. J. Peumans, P. Sarsfield, and U. Schumacher. 1996. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. 105:459-465.
31. Sutton, P. 2007. Considering increased mouse stomach mass, when calculating prophylactic vaccine efficacy against Helicobacter pylori. Helicobacter 12:210-212.
32. Sutton, P., S. J. Danon, M. Walker, L. J. Thompson, J. Wilson, T. Kosaka, and A. Lee. 2001. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 49:467-473.
33. Sutton, P., C. Doidge, G. Pinczower, J. Wilson, S. Harbour, A. Swierczak, and A. Lee. 2007. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol. Med. Microbiol. 50:213-219.
34. Sutton, P., J. Wilson, T. Kosaka, I. Wolowczuk, and A. Lee. 2000. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol. 78:28-30.
35. Terahara, K., M. Yoshida, O. Igarashi, T. Nochi, G. S. Pontes, K. Hase, H. Ohno, S. Kurokawa, M. Mejima, N. Takayama, Y. Yuki, A. W. Lowe, and H. Kiyono. 2008. Comprehensive gene expression profiling of Peyer's patchMcells, villous M-like cells, and intestinal epithelial cells. J. Immunol. 180:7840-7846.
36. Vuckovic, D., M. Abram, M. Bubonja, B. Wraber, and M. Doric. 2006. Host resistance to primary and secondary Campylobacter jejuni infections in C57BL/6 mice. Microb. Pathog. 40:35-39.
37. Yuki, N., and M. Koga. 2006. Bacterial infections in Guillain-Barre and Fisher syndromes. Curr. Opin. Neurol. 19:451-457.
38. Zilbauer, M., N. Dorrell, B. W. Wren, and M. Bajaj-Elliott. 2008. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans. R. Soc. Trop. Med. Hyg. 102:123-129.